The institute's Scientific Advisory Board

To ensure the high quality of scientific research in the long term, all institutes of the Max Planck Society are regularly reviewed by independent advisory boards. Tailored to the respective field of research, the advisory board is composed of experts from leading research institutions and universities worldwide. The Advisory Board evaluates the resource allocation of the departments and research groups. This ensures that only cutting-edge research areas of the highest international standard are addressed. The members of the Advisory Board are selected by the President of the Max Planck Society on the basis of proposals from the institute and appointed for a maximum term of six years, with a replacement of some of the members every three years..

These are the members of the institute’s advisory board:

• Prof. Dr. Paola Arlotta
  Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, USA

• Prof. Dr. Claudia Bagni 
  Département des neurosciences fondamentales, Université de Lausanne, Lausanne, Switzerland

• Prof. Dr. Yang Dan, 
  Department of Molecular & Cell Biology, University of California, Berkeley, USA

• Prof. Dr. Michael Jennions
  Research School of Biology, Evolution & Genetics, The Australian National University, Canberra, Australia

• Prof. Dr. Walter D. Koenig
  Lab of Ornithology, Cornell University, Carmel Valley, USA

• Prof. Dr. Liqun Luo
  Department of Biological Sciences, Stanford University, Stanford, USA

• Prof. Dr. Adriana Maggi
  Molecular Pharmacology Lab, Università degli Studi di Milano, Milano, Italy

• Prof. Dr. Oscar Marin 
  MRC Centre for Developmental Neurobiology, King’s College London, London, UK

• Prof. Dr. Hitoshi Okamoto
  RIKEN Center for Brain Science, Saitama, Japan

• Prof. Dr. Botond Roska
  Institute of Molecular and Clinical Ophthalmology Basel, Switzerland